account(MARKETWIRE via COMTEX) -- Poniard Pharmaceuticals, Inc. /quotes/comstock/15*!pard/quotes/nls/pard PARD +3.03% , a biopharmaceutical company focused on innovative oncology therapies, today reported financial results for the first quarter ended...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Poniard Pharmaceuticals Reports First Quarter 2011 Financial Results
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account